Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease

PHASE3CompletedINTERVENTIONAL

Enrollment

1,118

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

March 31, 2004

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Ipratropium bromide / Salbutamol

DRUG

Placebo Inhalation solution

DRUG

Ipratropium bromide

DRUG

COMBIVENT Inhalation Aerosol

DRUG

Placebo Inhalation Aerosol